MINISO (NYSE:MNSO) shows strong growth fundamentals and a technical breakout setup, making it an interesting candidate for investors seeking growth with momentum.
EMBRAER SA (NYSE:ERJ) shows explosive earnings growth, strong revenue momentum, and a bullish technical setup, making it a standout for high-growth investors.
Sanofi (SNY) to acquire Vigil Neuroscience (VIGL) for $470 million in cash, plus potential $2 per share payout. Acquisition excludes monoclonal antibody program and is expected to be finalized in Q3 2025. VG-3927 showed promise in Phase 1 for Alzheimer's treatment.
REMITLY GLOBAL INC (NASDAQ:RELY) combines strong revenue growth, earnings momentum, and a solid technical setup, making it a candidate for high-growth investors.
Asian stocks declined while Treasuries stabilised following a sell-off driven by worries over a proposed tax-cut bill that could increase the US deficit.
Membership-only discount retailer BJ’s Wholesale Club (NYSE:BJ) missed Wall Street’s revenue expectations in Q1 CY2025 as sales rose 4.8% year on year to $5.15 billion. Its non-GAAP profit of $1.14 per share was 25.1% above analysts’ consensus estimates.
CAL-MAINE FOODS INC (NASDAQ:CALM) offers a high 14.41% dividend yield, strong profitability, and a debt-free balance sheet, making it a standout for dividend investors.
Manufacturer of analog chips Analog Devices (NASDAQ:ADI) reported revenue ahead of Wall Street’s expectations in Q1 CY2025, with sales up 22.3% year on year to $2.64 billion. On top of that, next quarter’s revenue guidance ($2.75 billion at the midpoint) was surprisingly good and 4.5% above what analysts were expecting. Its non-GAAP profit of $1.85 per share was 9.1% above analysts’ consensus estimates.
WILLIAMS-SONOMA INC (NYSE:WSM) offers strong earnings growth, high profitability, and a debt-free balance sheet, making it a compelling choice for GARP investors. Read the full analysis for details.
Industrial process heating solutions provider Thermon (NYSE:THR) met Wall Street’s revenue expectations in Q1 CY2025, with sales up 5% year on year to $134.1 million. On the other hand, the company’s full-year revenue guidance of $515 million at the midpoint came in 4.1% below analysts’ estimates. Its non-GAAP profit of $0.56 per share was 10.9% above analysts’ consensus estimates.
Google's Veo 3 is stunning the internet with hyper-realistic AI videos featuring sound and dialogue, but most users are frustrated they can't access it without a $249 subscription or enterprise credentials.
Industrial products company CSW (NASDAQ:CSWI) fell short of the market’s revenue expectations in Q1 CY2025, but sales rose 9.3% year on year to $230.5 million. Its non-GAAP profit of $2.24 per share was 1.1% above analysts’ consensus estimates.
PAYCOM SOFTWARE INC (NYSE:PAYC) meets key quality investing criteria with strong ROIC, zero debt, and solid growth. A high profitability score supports its long-term potential.
Auto parts and accessories retailer Advance Auto Parts (NYSE:AAP) reported Q1 CY2025 results topping the market’s revenue expectations, but sales fell by 6.8% year on year to $2.58 billion. The company expects the full year’s revenue to be around $8.5 billion, close to analysts’ estimates. Its non-GAAP loss of $0.22 per share was 68% above analysts’ consensus estimates.
Elon Musk's Department of Government Efficiency initiative has assigned a review team to examine operations at the National Transportation Safety Board, marking another expansion of DOGE's oversight into independent federal agencies amid mounting transportation safety concerns.
Personal-finance guru Dave Ramsey dismissed Bitcoin (CRYPTO: BTC) investors as “stupid,” adding, “you're gonna lose your money” during a February 2014 radio show, when the cryptocurrency closed at $549.26 per coin.
PTC THERAPEUTICS (NASDAQ:PTCT) offers strong growth potential with reasonable valuation, solid profitability, and financial health, making it an interesting stock for growth investors.
The State Department's Bureau of Population, Refugees and Migration will assume leadership of U.S. overseas disaster response operations from the dismantled U.S. Agency for International Development, raising concerns among disaster relief experts about the office's preparedness for managing international humanitarian crises.
Robert F. Kennedy Jr. faces mounting pressure from Republican lawmakers and farming communities as his highly anticipated "Make America Healthy Again" report approaches Thursday's release.
David Sacks, the top crypto and AI advisor to President Donald Trump, has projected that the impending stablecoin legislation could unlock trillions for the U.S. Treasury.
EXELIXIS INC (NASDAQ:EXEL) offers strong growth, solid profitability, and an attractive valuation, making it a compelling choice for investors seeking affordable growth stocks in the biotech sector.
